부산대학교 도서관

Spasevska I; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; KG Jebsen Centre for B-cell malignancies, Institute of Clinical Medicine, University of Oslo, Norway.; Precision Immunotherapy Alliance, University of Oslo, Oslo, Norway.; Sharma A; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; KG Jebsen Centre for B-cell malignancies, Institute of Clinical Medicine, University of Oslo, Norway.; Precision Immunotherapy Alliance, University of Oslo, Oslo, Norway.; Steen CB; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; KG Jebsen Centre for B-cell malignancies, Institute of Clinical Medicine, University of Oslo, Norway.; Precision Immunotherapy Alliance, University of Oslo, Oslo, Norway.; Division of Oncology, Stanford University School of Medicine, Stanford, CA.; Josefsson SE; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; KG Jebsen Centre for B-cell malignancies, Institute of Clinical Medicine, University of Oslo, Norway.; Blaker YN; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; KG Jebsen Centre for B-cell malignancies, Institute of Clinical Medicine, University of Oslo, Norway.; Kolstad A; KG Jebsen Centre for B-cell malignancies, Institute of Clinical Medicine, University of Oslo, Norway.; Department of Oncology, Innlandet Hospital Trust, Lillehammer, Norway.; Division of Cancer Medicine, Department of Oncology, Oslo University Hospital, Oslo, Norway.; Rustad EH; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Precision Immunotherapy Alliance, University of Oslo, Oslo, Norway.; Meyer S; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Precision Immunotherapy Alliance, University of Oslo, Oslo, Norway.; Isaksen K; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; KG Jebsen Centre for B-cell malignancies, Institute of Clinical Medicine, University of Oslo, Norway.; Precision Immunotherapy Alliance, University of Oslo, Oslo, Norway.; Chellappa S; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Kushekhar K; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; KG Jebsen Centre for B-cell malignancies, Institute of Clinical Medicine, University of Oslo, Norway.; Beiske K; KG Jebsen Centre for B-cell malignancies, Institute of Clinical Medicine, University of Oslo, Norway.; Division of Cancer Medicine, Department of Pathology, Oslo University Hospital, Oslo, Norway.; Førsund MS; Division of Cancer Medicine, Department of Pathology, Oslo University Hospital, Oslo, Norway.; Spetalen S; Division of Cancer Medicine, Department of Pathology, Oslo University Hospital, Oslo, Norway.; Holte H; KG Jebsen Centre for B-cell malignancies, Institute of Clinical Medicine, University of Oslo, Norway.; Division of Cancer Medicine, Department of Oncology, Oslo University Hospital, Oslo, Norway.; Østenstad B; KG Jebsen Centre for B-cell malignancies, Institute of Clinical Medicine, University of Oslo, Norway.; Division of Cancer Medicine, Department of Oncology, Oslo University Hospital, Oslo, Norway.; Brodtkorb M; KG Jebsen Centre for B-cell malignancies, Institute of Clinical Medicine, University of Oslo, Norway.; Division of Cancer Medicine, Department of Oncology, Oslo University Hospital, Oslo, Norway.; Kimby E; Department of Hematology, Karolinska Institute, Stockholm, Sweden.; Olweus J; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Precision Immunotherapy Alliance, University of Oslo, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Norway.; Taskén K; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; KG Jebsen Centre for B-cell malignancies, Institute of Clinical Medicine, University of Oslo, Norway.; Newman AM; Division of Oncology, Stanford University School of Medicine, Stanford, CA.; Divisions of Hematology & Oncology, Department of Medicine, Stanford University, Stanford, CA.; Lorenz S; Department of Core Facilities, Geonomics Core Facility, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Smeland EB; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; KG Jebsen Centre for B-cell malignancies, Institute of Clinical Medicine, University of Oslo, Norway.; Precision Immunotherapy Alliance, University of Oslo, Oslo, Norway.; Alizadeh AA; Division of Oncology, Stanford University School of Medicine, Stanford, CA.; Divisions of Hematology & Oncology, Department of Medicine, Stanford University, Stanford, CA.; Huse K; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; KG Jebsen Centre for B-cell malignancies, Institute of Clinical Medicine, University of Oslo, Norway.; Precision Immunotherapy Alliance, University of Oslo, Oslo, Norway.; Myklebust JH; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; KG Jebsen Centre for B-cell malignancies, Institute of Clinical Medicine, University of Oslo, Norway.; Precision Immunotherapy Alliance, University of Oslo, Oslo, Norway.

Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

Switlyk MD; Department of Radiology, Radiumhospitalet, Oslo University Hospital, Postboks 4953, Nydalen, 0424, Oslo, Norway. marta.switlyk@ous-hf.no.; Skeie AT; Department of Radiology, Radiumhospitalet, Oslo University Hospital, Postboks 4953, Nydalen, 0424, Oslo, Norway.; Lund-Iversen M; Department of Pathology, Radiumhospitalet, Oslo University Hospital, Oslo, Norway.; Østenstad B; Department of Oncology, Radiumhospitalet, Oslo University Hospital, Oslo, Norway.

Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE

Pulczynski EJ; Department of Haematology, Aarhus University Hospital, Aarhus, Denmark; Department of Haematology, Region Hospital Goedstrup, Herning.; Simonsen MR; Department of Hematology, Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark; Department of Mathematical Sciences, Aalborg University, Aalborg.; Kuittinen O; Department of Oncology, Kuopio University Hospital Cancer Center, Kuopio, Finland; Faculty of Medicine, Institute of Clinical Medicine, University of Eastern Finland, Kuopio.; Fagerli UM; Department of Oncology, St Olav University Hospital, Trondheim, Norway; Department of Clinical and Molecular Medicine, Norwegian University of science and technology (NTNU), Trondheim, Norway.; Erlanson M; Department of Radiation Sciences, Umeå University, Umeå, Sweden.; Fluge Ø; Department of Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norway.; Leppä S; Research Programs Unit/Applied Tumor Genomics Research Program, University of Helsinki, Helsinki, Finland; Department of Oncology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki.; Østenstad B; Department of Oncology, Oslo University Hospital, Oslo, Norway.; Fosså A; Department of Oncology, Oslo University Hospital, Oslo, Norway; KG Jebsen Centre for B-cell Malignancies, University of Oslo, Oslo, Norway.; Eriksson M; Department of Oncology, Skane University Hospital, Lund, Sweden; Medical Oncology, Lund University, Lund, Sweden.; El-Galaly T; Department of Hematology, Aalborg University Hospital, Aalborg.; Kuitunen H; Cancer Centre, Oulu University Hospital, Oulu.; Papworth K; Department of Radiation Sciences, Umeå University, Umeå, Sweden.; Ljungqvist M; Department of Clinical Science and Education, Södersjukhuste, Karolinska Insitutet, Stockholm, Sweden; Haematology Centre, Karolinska University Hospital, Stockholm, Sweden.; Pedersen MB; Department of Haematology, Aarhus University Hospital, Aarhus.; Pollari M; Research Programs Unit/Applied Tumor Genomics Research Program, University of Helsinki, Helsinki, Finland; Department of Oncology, Tays Cancer Center, Tampere University Hospital, Tampere. marjukka.pollari@pirha.fi.

Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE

Holte, H.; Lauritzsen, G.; Kvaløy, S.; Kolstad, A.; Telhaug, R.; Hammerstrøm, J.; Østenstad, B.; Maisenhølder, M.; Ekanger, R.; Jacobsen, A-B.; Kvalheim, G.

Bone Marrow Transplantation. Mar 01, 2005 35 Suppl 2:S9-S10

Spasevska, I.; Sharma, A.; Steen, C. B.; Josefsson, S. E.; Blaker, Y. N.; Kolstad, A.; Rustad, E. H.; Meyer, S.; Chellappa, S.; Kushekhar, K.; Beiske, K.; Førsund, M.; Holte, H.; Østenstad, B.; Brodtkorb, M.; Kimby, E.; Olweus, J.; Tasken, K.; Newman, A.; Lorenz, S.

Hematological Oncology; Jun2023 Supplement 1, Vol. 41, p39-39, 1p

Østenstad, B.; Pirosa, M. C.; Schär, S.; Brodtkorb, M.; Wahlin, B. E.; Hernberg, M.; Pedersen, M.; Stathis, A.; Zander, T.; Novak, U.; Zenz, T.; Fischer, N.; Krasniqi, F.; Hitz, F.; Jjohansson, A.; Lofgren, D.; Meyer, P.; Bjørnevik, A. T.; Hayoz, S.; Scheibe, B.

Hematological Oncology; Jun2023 Supplement 1, Vol. 41, p117-119, 3p

Josefsson SE; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; KG Jebsen Centre for B-cell Malignancies, Institute for Clinical Medicine, University of Oslo, Oslo, Norway.; Beiske K; Department of Pathology, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway.; Blaker YN; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; KG Jebsen Centre for B-cell Malignancies, Institute for Clinical Medicine, University of Oslo, Oslo, Norway.; Førsund MS; Department of Pathology, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway.; Holte H; KG Jebsen Centre for B-cell Malignancies, Institute for Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Oncology, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway.; Østenstad B; Department of Oncology, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway.; Kimby E; Department of Hematology, Karolinska Institutet, Stockholm, Sweden.; Köksal H; KG Jebsen Centre for B-cell Malignancies, Institute for Clinical Medicine, University of Oslo, Oslo, Norway.; Section for Cellular Therapy, Department for Cancer Treatment, Oslo University Hospital, Oslo, Norway.; Wälchli S; KG Jebsen Centre for B-cell Malignancies, Institute for Clinical Medicine, University of Oslo, Oslo, Norway.; Section for Cellular Therapy, Department for Cancer Treatment, Oslo University Hospital, Oslo, Norway.; Bai B; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; KG Jebsen Centre for B-cell Malignancies, Institute for Clinical Medicine, University of Oslo, Oslo, Norway.; Smeland EB; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; KG Jebsen Centre for B-cell Malignancies, Institute for Clinical Medicine, University of Oslo, Oslo, Norway.; Levy R; Division of Oncology, Stanford School of Medicine, Stanford, California.; Kolstad A; Department of Oncology, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway.; Huse K; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; KG Jebsen Centre for B-cell Malignancies, Institute for Clinical Medicine, University of Oslo, Oslo, Norway.; Myklebust JH; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. June.Helen.Myklebust@rr-research.no.; KG Jebsen Centre for B-cell Malignancies, Institute for Clinical Medicine, University of Oslo, Oslo, Norway.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101614637 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2326-6074 (Electronic) Linking ISSN: 23266066 NLM ISO Abbreviation: Cancer Immunol Res Subsets: MEDLINE

Eide MB; Centre for Cancer Biomedicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Lauritzsen GF; Kvalheim G; Kolstad A; Fagerli UM; Maisenhölder M; Østenstad B; Fluge Ø; Delabie J; Aarset H; Liestøl K; Holte H

Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE

Kiserud CE; National Advisory Unit for Late Effects after Cancer, Oslo University Hospital, Oslo, Norway.; Lockmer S; Department of Medicine, Center for Hematology and Regenerative Medicine, Stockholm, Sweden.; Karolinska Institutet, and Hematology Center, Karolinska University Hospital, Stockholm, Sweden.; Baerug I; National Advisory Unit for Late Effects after Cancer, Oslo University Hospital, Oslo, Norway.; Dahl AA; National Advisory Unit for Late Effects after Cancer, Oslo University Hospital, Oslo, Norway.; Kimby E; Department of Medicine,Unit of Hematology, Karolinska Institutet, Stockholm, Sweden.; Østenstad B; Department of Oncology, Oslo University Hospital, Oslo, Norway.

Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE

Negaard, H F S; Iversen, N; Bowitz-Lothe, I M; Sandset, P M; Steinsvik, B; Østenstad, B; Iversen, P O

Leukemia. 23(1):162-169